Post job

Rapid Micro Biosystems's revenue is $28.1 million.

What is Rapid Micro Biosystems's revenue?

Rapid Micro Biosystems's annual revenue is $28.1M. Zippia's data science team found the following key financial metrics about Rapid Micro Biosystems after extensive research and analysis.
  • Rapid Micro Biosystems's revenue growth from 2020 to 2024 is 74.48%.
  • Rapid Micro Biosystems has 158 employees, and the revenue per employee ratio is $177,537.
  • Rapid Micro Biosystems's peak quarterly revenue was $8.2M in 2024(q4).
  • Rapid Micro Biosystems peak revenue was $28.1M in 2024.
  • Rapid Micro Biosystems annual revenue for 2023 was 22.5M, 31.44% growth from 2022.
  • Rapid Micro Biosystems annual revenue for 2024 was 28.1M, 24.57% growth from 2023.

On this page

Most recent quarter revenue
$8.2M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$28.1M (2024)
Company peak revenue
Revenue / employee
$177,538
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$8.2M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$28.1M (2024)
Company peak revenue
Revenue / employee
$177,538
Company revenue / employee

Rapid Micro Biosystems historical revenue

Rapid Micro Biosystems annual revenue

$28M
$22M
$17M
$11M
$6M
$0
2020
2021
2022
2023
2024

Rapid Micro Biosystems annual revenue over time

Fiscal year / yearRapid Micro Biosystems revenue
2020$16.1M
2021$23.2M
2022$17.1M
2023$22.5M
2024$28.1M

Rate Rapid Micro Biosystems' financial transparency

Zippia waving zebra

Rapid Micro Biosystems annual growth

Rapid Micro Biosystems annual growth rate over time

YearRapid Micro Biosystems growth
2021
45%
2022
-26%
2023
31%
2024
25%

Rapid Micro Biosystems jobs nearby

Do you work at Rapid Micro Biosystems?

Did Rapid Micro Biosystems meet its revenue projections?

Rapid Micro Biosystems financing

Rapid Micro Biosystems received early financing of $18.6M on 2009-08-06.

SeriesRound sizeDate
Series A$18.6M08/2009
Series Unknown$6.7M09/2010
Debt Financing$2.5M04/2012
Series B$32.6M06/2013
Series Unknown$6M04/2014
Debt Financing$6M03/2015
Series C$25M04/2015
Private Equity$60M05/2018
Private Equity$120M05/2020
Private Equity$81M03/2021

Rapid Micro Biosystems investors

InvestorsSecurity type
TVM CapitalSeries A
Kleiner PerkinsSeries A
Quaker PartnersSeries A
VIMAC Milestone Medical FundSeries A
TVM CapitalSeries B
Longitude CapitalSeries B
TPG BiotechSeries B
Kleiner PerkinsSeries B
Quaker PartnersSeries B
TVM CapitalSeries Unknown
Longitude CapitalSeries Unknown
Kleiner PerkinsSeries Unknown
TPG BiotechSeries Unknown
Quaker PartnersSeries Unknown
HepalinkSeries C
TVM CapitalSeries C
Longitude CapitalSeries C
TPG BiotechSeries C
Kleiner PerkinsSeries C
Quaker PartnersSeries C
Bain Capital Life SciencesPrivate Equity
Xeraya CapitalPrivate Equity
Endeavour VisionPrivate Equity
Ally Bridge GroupPrivate Equity
Bain Capital Life SciencesPrivate Equity
Xeraya CapitalPrivate Equity
Longitude CapitalPrivate Equity
Asahi Kasei Medical EuropePrivate Equity
Sunley House Capital ManagementPrivate Equity
D1 Capital PartnersPrivate Equity
Adage Capital ManagementPrivate Equity
T. Rowe PricePrivate Equity
CaaS Capital ManagementPrivate Equity
BlackRock, Inc.Private Equity

Rapid Micro Biosystems competitors

Rapid Micro Biosystems's top competitor, Chembio Diagnostics, earned an annual revenue of $49.5B.

Rapid Micro Biosystems's smallest competitor is Quantum Group with revenue of $8.5M last year.

Rapid Micro Biosystems revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Rapid Micro Biosystems, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Rapid Micro Biosystems. The employee data is based on information from people who have self-reported their past or current employments at Rapid Micro Biosystems. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Rapid Micro Biosystems. The data presented on this page does not represent the view of Rapid Micro Biosystems and its employees or that of Zippia.

Rapid Micro Biosystems may also be known as or be related to RAPID MICRO BIOSYSTEMS, INC., Rapid Micro Biosystems and Rapid Micro Biosystems, Inc.